MedTrace Logo

Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic Antibiotics

NCT02212392 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-08-08

No results posted yet for this study

Summary

The use of prophylactic antibiotics is beneficial in reducing the extrapancreatic infections and shorter hospital stay in patients of acute pancreatitis as compared to controls.

Conditions

Interventions

DRUG

Meropenem

inj. MEROPENEM IV 1 gram twice daily at 12 hours interval for 7-10 days

Sponsors & Collaborators

  • Benazir Bhutto Hospital, Rawalpindi

    lead OTHER_GOV

Principal Investigators

  • Fazal H Shah, MBBS, FCPS I · Benazir Bhutto Hospital, Rawalpindi

  • Sohail Rashid, MBBS, FCPS · Benazir Bhutto Hospital, Rawalpindi

  • Bilal Altaf, MBBS, FCPS I · Benazir Bhutto Hospital, Rawalpindi

  • Muhammad Hanif, MBBS, FCPS · Benazir Bhutto Hospital, Rawalpindi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02212392 on ClinicalTrials.gov